1-(4-(Trifluoromethoxy)phenyl)-1H-pyrazole-4-carboxylic acid, 98%, 1g

5-AZASPIRO[2.3]HEXANE HCL, 95.0%, 100mg

6,11-Dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid, 97.0%, 10g

(4-Methylpiperidin-4-yl)(pyrrolidin-1-yl)methanone, 95.0%, 250mg

2,6-Di-tert-butyl-4-vinylphenol, 95.0%, 5g

(2E)-1-(3,4-dichlorophenyl)-3-(4-ethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(2S,4R)-4-METHOXY-2-METHYLPIPERIDINE HYDROCHLORIDE, 95%, 100mg

5-fluoro-4-hydrazino-2-methoxypyrimidine, 95.0%, 100g

1-(3-chloro-4-fluorophenyl)-3-(dimethylamino)prop-2-en-1-one, 250mg

Pentadecanedioic Acid>97.0%(GC)(T)10g

Methyl 4-oxochroman-8-carboxylate, 97.0%, 250mg

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 300m2/g)25g

2-(4-Bromophenoxy)-5-(trifluoromethyl)pyridine, 97%, 5g